Document is current

Article History

Received: 3 September 2024

Accepted: 4 October 2024

First Online: 23 October 2024

Declarations

:

: This study was conducted in accordance with the Declaration of Helsinki and each center received approval from their ethic committee.

: After having received approval from the local Ethics Committees, the investigators of each center invited eligible patients to participate. Patients who consented to participate were included in the study.

: Fabio Efficace had a consultancy or advisory role for AbbVie, Incyte, Syros, Novartis and JAZZ Pharmaceuticals and Research support (institution) from Daiichi Sankyo, all outside the submitted work.Uwe Platzbecker: honoraria: Abbvie, Curis, Janssen.Marco Vignetti reports honoraria from AbbVie, Amgen, AstraZeneca, Dephaforum Srl., Incyte Corporation, and Novartis; and personal fees from Amgen outside the submitted work.Massimo Breccia reports fees for expert witness testimony from Incyte Corporation, Novartis Pharma, and Pfizer, Inc., outside the submitted work; and he is also Editor-In-Chief of this journal.All other co‐authors declare no conflict of interest.